Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma

A new study led by researchers at the Centro Oncológico Johns Hopkins Kimmel found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of treatment.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

Colon Cancer Screening: What You Need to Know Detecting Early-Stage Cancers with a New Blood Test Measuring Epigenetic Instability Oral Bacterium May Promote Breast Cancer Development and Spread Extra Copies of Chromosome 1q May Drive Pancreatic Cancer How Bacteria May Promote Breast Cancer Growth of Spreading Pancreatic Cancer Fueled By “Under-Appreciated” Epigenetic Changes Updated Guidelines Standardize How Tumor Response Is Measured After Surgery Running the Distance: Patient Teams with Johns Hopkins Medicine Dermatologists to Treat, Understand Rare Hereditary Cancer Syndrome New Technology: MRI-guided Focused Ultrasound for Prostate Cancer